Fulcrum Therapeutics, Inc. (FULC)
3.76
-0.01
(-0.27%)
USD |
NASDAQ |
Sep 18, 16:00
3.765
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Free Cash Flow : -66.14M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -66.14M |
| March 31, 2026 | -63.88M |
| December 31, 2025 | -60.38M |
| September 30, 2025 | -60.41M |
| June 30, 2025 | -65.22M |
| March 31, 2025 | 7.559M |
| December 31, 2024 | -2.496M |
| September 30, 2024 | -8.739M |
| June 30, 2024 | -12.62M |
| March 31, 2024 | -92.50M |
| December 31, 2023 | -91.47M |
| September 30, 2023 | -88.05M |
| June 30, 2023 | -93.24M |
| March 31, 2023 | -100.95M |
| December 31, 2022 | -99.01M |
| September 30, 2022 | -101.58M |
| Date | Value |
|---|---|
| June 30, 2022 | -96.35M |
| March 31, 2022 | -86.06M |
| December 31, 2021 | -80.19M |
| September 30, 2021 | -78.11M |
| June 30, 2021 | -59.77M |
| March 31, 2021 | -55.71M |
| December 31, 2020 | -55.00M |
| September 30, 2020 | -39.30M |
| June 30, 2020 | -47.94M |
| March 31, 2020 | -45.90M |
| December 31, 2019 | -40.34M |
| September 30, 2019 | -45.60M |
| June 30, 2019 | -37.42M |
| March 31, 2019 | -34.34M |
| December 31, 2018 | -31.54M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cocrystal Pharma, Inc. | -8.276M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -208.80M |
| Definium Therapeutics, Inc. | -166.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.04M |
| Cash from Investing (Quarterly) | 13.78M |
| Cash from Financing (Quarterly) | 0.356M |
| Free Cash Flow Per Share (Quarterly) | -0.2117 |
| Free Cash Flow to Equity (Quarterly) | -15.56M |
| Free Cash Flow to Firm (Quarterly) | -16.15M |
| Free Cash Flow Yield | -25.05% |